Naloxone as mitochondrial phenotype rescuer in a 3D bioprinted LCHADD/VLCADD model
Naloxone restores mitochondrial structure and vascularization in a 3D bioprinted model of LCHADD/VLCADD, improving vessel network complexity by 50%.
- Why it matters: Patients with LCHADD and VLCADD face life-threatening crises during fasting or high-energy demands, but limited models hinder therapy development.
- What they did: Researchers used 3D bioprinted, vascularized tissue models and mitochondrial morphology analysis to test treatments, focusing on NOX2-driven ROS and metabolic supplementation.
- The result: Naloxone significantly improved mitochondrial integrity and vessel formation, indicating its potential as a safe rescue medication to mitigate metabolic crises in these disorders.